<!DOCTYPE html>
<html lang="en">
  <head>
    <meta charset="UTF-8" />
    <meta http-equiv="X-UA-Compatible" content="IE=edge" />
    <meta name="viewport" content="width=device-width, initial-scale=1.0" />

    <!----======== CSS ======== -->
    <link rel="stylesheet" href="../styles/interventions_pages.css" />
    <link rel="stylesheet" href="../styles/nav.css" />
    
    <!----======== JS ======== -->
    <script src="../js/plot_overview.js"></script> 

    <link
      rel="stylesheet"
      href="https://fonts.googleapis.com/css2?family=Material+Symbols+Outlined:opsz,wght,FILL,GRAD@48,400,0,0"
    />
    <link rel="icon" href="../img/profile_icon_inter.svg" />
    <link
      rel="stylesheet"
      href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.14.0/css/all.min.css"
    />
    <script src="https://cdnjs.cloudflare.com/ajax/libs/animejs/3.2.1/anime.min.js"></script>
    <script src="https://code.jquery.com/jquery-3.6.0.min.js"></script>
    <script src="https://code.jquery.com/ui/1.13.1/jquery-ui.min.js"></script>
    <script src="https://cdn.jsdelivr.net/npm/chart.js"></script>
  </head>
  <body><div class='desc_tab'>More information about<br>Vasopressin receptor antagonist (V1a-RA)</div><div class="btn_container"><a href="interventions.html" class="button"
                ><i class="far fa-arrow-alt-circle-left fa-2x"></i>Back to other
                interventions</a
                ></div><div class='hero'><div class='hero_image'><img src='https://ars.els-cdn.com/content/image/1-s2.0-S1521690X16000099-gr1.jpg' /></div><div class='hero_left'><div class='hero_history'></div><div class='hero_description'><div class='header_tab'>Description of Vasopressin receptor antagonist</div><p>The Vasopressin receptor antagonist V1a-RA is a key focus in anxiety and stress research. AVP affects brain regions involved in anxiety, such as the amygdala, and may be linked to anxiety disorders and post-traumatic stress disorder. Clinical studies show decreased AVP levels following anxiolytic treatment. V1a receptors are abundant in areas like the lateral septum and bed nucleus of the stria terminalis, which are involved in fear and anxiety regulation. </p><p>Animal studies have shown that V1a receptor antagonists reduce anxious behavior in various tests, suggesting their potential for anxiety treatment. Clinical research also indicates that genetic variations in the V1a receptor can influence amygdaloid activation to emotional stimuli. The V1a receptor antagonist SRX246 is being evaluated for its effects on non-social fear and anxiety in humans. These findings underscore the importance of targeting the V1a receptor in addressing both anxiety and fear, which may require distinct treatment approaches due to their different underlying neural circuits.</p></div></div></div><hr class="custom-hr"><div class='header_shalf'>Main features of Vasopressin receptor antagonist</div><div class='shalf'><div class='shalf_carac'><div class='card_carac_container'><div class='card_caracteristic'><div class='card_caracteristic_head'>Users of V1a-RA</div><div class='card_caracteristic_img'><div class='ul_age'><div class='adult'></div></div></div><div class='card_caracteristic_body'>The intervention is typically designed for Adults (>=20 yo), with <b>no specific cognitive difficulties</b>. </div></div><div class='card_caracteristic'><div class='card_caracteristic_head'>Implementation</div><div class='card_caracteristic_img'><div class='ul_age'><div class='homeT'></div></div></div><div class='card_caracteristic_body'>This type of intervention is delivered <b>at home</b>. It is mainly administered by <b>na</b>, and is supported by na. </div></div><div class='card_caracteristic'><div class='card_caracteristic_head'>Duration and dosage</div><div class='card_caracteristic_img'><div class='ul_age'><div class='medium'></div></div></div><div class='card_caracteristic_body'>On average this type of intervention lasts about <b>3 months</b> (from 1 days to 4 months), for an average of <b>8 mg/day</b> (from 5 mg/day</b> to 10 mg/day). </div></div></div></div><hr class="custom-hr"><div class='header_shalf'>Evidence about efficacy and safety of<br> Vasopressin receptor antagonist</div><div class='canva_description'><div class='header_tab_plot'>Presentation of the efficacy</div><div id='canva_description_efficacy'><div class="circle" data-hover-text="Very strong effect in favor of controls"></div><div class="circle" data-hover-text="Moderate-to-strong effect in favor of controls"></div><div class="circle" data-hover-text="Small-to-moderate effect in favor of controls"></div><div class="circle" data-hover-text="No difference between Vasopressin receptor antagonist and controls"></div><div class="circle" data-hover-text="Small-to-moderate effect in favor of Vasopressin receptor antagonist"></div><div class="circle" data-hover-text="Moderate-to-strong effect in favor of Vasopressin receptor antagonist"></div><div class="circle" data-hover-text="Very strong effect in favor of Vasopressin receptor antagonist"></div><div id="hoverText_efficacy"></div></div><div class='header_tab_plot'>Presentation of the number of studies</div><div id='canva_description_size'><div class="circle size" data-hover-text="n-studies = minimum"></div><div class="circle size" data-hover-text="n-studies = maximum"></div><div id="hoverText_size"></div></div><div class='header_tab_plot'>Presentation of the confidence (GRADE) rating</div><div id='canva_description_grade'><div class="circle size" data-hover-text="GRADE = Very low"></div><div class="circle size" data-hover-text="GRADE = Low"></div><div class="circle size" data-hover-text="GRADE = Moderate"></div><div class="circle size" data-hover-text="GRADE = High"></div><div id="hoverText_grade"></div></div></div><div id = "contain_helper"><div id = "img_helper"></div><div id="labelCard"></div></div><div class="container_canvas"><canvas id="myScatterPlot"></canvas></div><hr class="custom-hr"><div class='bottom_ressources'><div class='header_shalf'>Additional resources</div><div class='header_tab'>Links to identified meta-analyses for V1a-RA</div><div class='ressources'><ul class='hrztl_list'><li> <a href='https://doi.org/10.1002/jdn.10297' target='_blank'>Kimi (2023)</a></li><li> <a href='https://doi.org/10.1002/14651858.CD011769.pub2' target='_blank'>Iffland (2023)</a></li></ul></div><br><div class='header_tab'>Additional ressources</div><div class='ressources'><ul><li><a href='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3859978/pdf/fnsys-07-00100.pdf' target='_blank'>Lee RJ, Coccaro EF, Cremers H et al. (2013) A novel V1a receptor antagonist blocks vasopressin-induced changes in the CNS response to emotional stimuli: an fMRI study. Front Syst Neurosci 7:1–11</li></a><li><a href='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2754603/' target='_blank'>Meyer-Lindenberg A, Kolachana B, Gold B et al. (2009) Genetic variants in AVPR1A linked to autism predict amygdala activation and personality traits in healthy humans. Mol Psychiatry 14:968–975</li></a><ul></div></div><script>createScatterPlot('../js/V1a-RA.json');</script><script>
      const circlesEfficacy = document.querySelectorAll('#canva_description_efficacy .circle');
      const hoverTextEfficacy = document.getElementById('hoverText_efficacy');
      
      circlesEfficacy.forEach(circle => {
        circle.addEventListener('mouseover', () => {
          hoverTextEfficacy.textContent = circle.getAttribute('data-hover-text');
          hoverTextEfficacy.style.opacity = '1';
        });
        
        circle.addEventListener('mouseout', () => {
          hoverTextEfficacy.textContent = '';
          hoverTextEfficacy.style.opacity = '1';
        });
      });
      
      // Hover text for Size
      const circlesSize = document.querySelectorAll('#canva_description_size .circle');
      const hoverTextSize = document.getElementById('hoverText_size');
      
      circlesSize.forEach((circle, index) => {
        circle.style.width = `${10 + index * 30}px`;
        circle.style.height = `${10 + index * 30}px`;
        circle.addEventListener('mouseover', () => {
          hoverTextSize.textContent = circle.getAttribute('data-hover-text');
          hoverTextSize.style.opacity = '1';
        });
        
        circle.addEventListener('mouseout', () => {
          hoverTextSize.style.opacity = '0';
        });
      });
      
      // Hover text for Grade
      const circlesGrade = document.querySelectorAll('#canva_description_grade .circle');
      const hoverTextGrade = document.getElementById('hoverText_grade');
      
      circlesGrade.forEach((circle, index) => {
        if (index === 0) {
          circle.style.border = '2px dashed #ff8b1a';
        } else if (index === 1) {
          circle.style.border = '2px solid #de5c3a';
        } else if (index === 2)  {
          circle.style.border = `5px solid #ad2b5b`;
        } else if (index === 3)  {
          circle.style.border = `8px solid #3d0173`;
        }
        circle.addEventListener('mouseover', () => {
          hoverTextGrade.textContent = circle.getAttribute('data-hover-text');
          hoverTextGrade.style.opacity = '1';
        });
        
        circle.addEventListener('mouseout', () => {
          hoverTextGrade.style.opacity = '0';
        });
      });</script></body>
  </html>
